Načítá se...

The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.

Using the breast carcinoma cell line MDA-MB 468 as immunogen, we have produced six new rat monoclonal antibodies (mAbs) against the human EGF receptor (EGFR) and are investigating their use for diagnostic and therapeutic applications in cancer patients whose tumours overexpress these receptors. The...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Modjtahedi, H., Styles, J. M., Dean, C. J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1993
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968163/
https://ncbi.nlm.nih.gov/pubmed/8094290
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!